Sunshine Biopharma Inc (SBFM)

03:15 AM

Sunshine Biopharma (NASDAQ:SBFMW) Stock Price Down 4.5% – Here’s Why - Defense World

03:15 AM

Apr 24, 2025

There is no doubt that Sunshine Biopharma Inc (SBFM) ticks all the boxes. - Sete News

Apr 24, 2025

Apr 23, 2025

Sunshine Becomes Latest To Compete On Everolimus In Canada - insights.citeline.com

Apr 23, 2025

Apr 22, 2025

Sunshine Biopharma Boosts Retail Trader Appeal After Canadian Launch Of Generic Cancer Drug - NewsBreak: Local News & Alerts

Apr 22, 2025

Apr 21, 2025

Sunshine Biopharma Boosts Retail Trader Appeal After Canadian Launch Of Generic Cancer Drug By Stocktwits - Investing.com India

Apr 21, 2025

Apr 21, 2025

SBFM Stock: A Comprehensive Analysis and Forecast - investchronicle.com

Apr 21, 2025

Apr 21, 2025

Sunshine Biopharma enters Canadian generic drug market with Everolimus By Investing.com - Investing.com South Africa

Apr 21, 2025

Apr 21, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 21, 2025

Apr 21, 2025

SBFM’s valuation metrics: A comprehensive analysis - uspostnews.com

Apr 21, 2025

Apr 21, 2025

Sunshine Biopharma (SBFM) Finalizes $2.46 Million Stock Offering - GuruFocus

Apr 21, 2025

Apr 21, 2025

Sunshine Biopharma Unit Rolls Out Afinitor Alternative Everolimus in Canadian Market - marketscreener.com

Apr 21, 2025

Apr 21, 2025

Sunshine Biopharma enters Canadian generic drug market with Everolimus - Investing.com

Apr 21, 2025

Apr 21, 2025

Sunshine Biopharma (SBFM) Launches Generic Everolimus in Canada | SBFM Stock News - GuruFocus

Apr 21, 2025

Apr 21, 2025

Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion | SBFM Stock News - GuruFocus

Apr 21, 2025

Apr 21, 2025

Major Cancer Treatment Everolimus Enters Canadian Market: Multiple Cancer Types Targeted in $2.5B Opportunity - Stock Titan

Apr 21, 2025

Apr 16, 2025

Sunshine Biopharma stock hits 52-week low at $1.24 - Investing.com Australia

Apr 16, 2025

Apr 16, 2025

Sunshine Biopharma stock hits 52-week low at $1.24 By Investing.com - Investing.com India

Apr 16, 2025

Apr 04, 2025

Sunshine Biopharma (NASDAQ:SBFMW) Trading Down 10.9% – Here’s Why - Defense World

Apr 04, 2025

Apr 03, 2025

Sunshine Biopharma stock hits 52-week low at $1.85 amid steep decline By Investing.com - Investing.com South Africa

Apr 03, 2025

Apr 03, 2025

Sunshine Biopharma Secures $2.46 Million in Direct Offering - TipRanks

Apr 03, 2025

Apr 03, 2025

Sunshine Biopharma Closes $2.5 Million Direct Offering - MarketScreener

Apr 03, 2025

Apr 03, 2025

Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering - ACCESS Newswire

Apr 03, 2025

Apr 03, 2025

SEC Form 424B5 filed by Sunshine Biopharma Inc. - Quantisnow

Apr 03, 2025

Apr 03, 2025

Sunshine Biopharma stock hits 52-week low at $1.85 amid steep decline - Investing.com India

Apr 03, 2025

Apr 03, 2025

Sunshine Biopharma’s K1.1-mRNA-LNP shows promise in HCC mouse model - BioWorld MedTech

Apr 03, 2025

Apr 03, 2025

The time has not yet come to remove your chips from the table: Sunshine Biopharma Inc (SBFM) - Sete News

Apr 03, 2025

Apr 02, 2025

Sunshine Biopharma secures $2.46 million in stock offering By Investing.com - Investing.com Canada

Apr 02, 2025

Apr 02, 2025

Sunshine Biopharma Reports 78% Revenue Growth and Key Developments in 2022 - TipRanks

Apr 02, 2025

Apr 02, 2025

Sunshine Biopharma (SBFM) Reports Increased Revenue Despite Net Loss - GuruFocus

Apr 02, 2025

Apr 02, 2025

Sunshine Biopharma (SBFM) Secures $2.46 Million in Direct Stock Offering - GuruFocus

Apr 02, 2025

Apr 02, 2025

Sunshine Biopharma secures $2.46 million in stock offering - Investing.com

Apr 02, 2025

Apr 02, 2025

Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules - ACCESS Newswire

Apr 02, 2025

Apr 02, 2025

Sunshine Biopharma Stock Shoots Higher On Encouraging Data From mRNA-Based Liver Cancer Drug - Benzinga

Apr 02, 2025

Apr 02, 2025

Biotech Stock Sunshine Biopharma Inc. (NASDAQ:SBFM) Makes NASDAQ Top Gainer List on News - Investorideas.com

Apr 02, 2025

Apr 02, 2025

This Pharma Stock Is Gaining Major Steam Ahead Of Opening Bell - The Globe and Mail

Apr 02, 2025

Apr 02, 2025

From Underdog to Top Performer: Sunshine Biopharma’s Impressive Surge - timothysykes.com

Apr 02, 2025

Apr 02, 2025

Sunshine Biopharma (SBFM) Announces Promising Results for Liver Cancer Treatment - GuruFocus

Apr 02, 2025

Apr 02, 2025

Sunshine Biopharma reports progress in liver cancer treatment - Investing.com India

Apr 02, 2025

Apr 02, 2025

Sunshine Biopharma Completes Additional Studies of mRNA Therapy for Liver Cancer; Shares Up Pre-Bell - MarketScreener

Apr 02, 2025

Apr 02, 2025

Pre-market Movers: IBG, JYD, SBFM, SPWH, RSLS… - RTTNews

Apr 02, 2025

Apr 02, 2025

Revolutionary mRNA Treatment Succeeds Against Deadly Liver Cancer in Latest Trial - Stock Titan

Apr 02, 2025

Apr 01, 2025

Sunshine Biopharma (SBFM) Reports 2024 Financial Highlights - GuruFocus

Apr 01, 2025

Apr 01, 2025

Sunshine Biopharma Reports Record Revenue: 13 New Drugs and Cancer Treatment Breakthrough - Stock Titan

Apr 01, 2025

Apr 01, 2025

Sunshine Biopharma Inc. SEC 10-K Report - TradingView

Apr 01, 2025

Mar 28, 2025

Sunshine Biopharma Inc expected to post earnings of 11 cents a shareEarnings Preview - TradingView

Mar 28, 2025

Mar 25, 2025

Sunshine Biopharma signs agreement for rights to market two generic antibiotics - Yahoo Finance

Mar 25, 2025

Mar 24, 2025

Sunshine Biopharma to market new antibiotics in Canada By Investing.com - Investing.com Australia

Mar 24, 2025

Mar 24, 2025

Sunshine Biopharma acquires marketing rights for two new antibiotics in Canada - MSN

Mar 24, 2025